Product Information
CLONIDINE HCL ER 0.1 MG TABLET is a generic product labeled by BluePoint Laboratories, priced at $0.2117 per EA under NDC 68001056806. Its NADAC has been published 160 times since Sep 13, 2023.
FDA first approved this application on Nov 20, 2017. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
.1 mg/1
Manufacturer
BluePoint LaboratoriesNDC
68001056806
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
CLONIDINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA209686FDA Approved
11/20/2017
TE Code
AB1
On Market Since
8/24/2023
Pharmacological Classes
Price Statistics
The NADAC for CLONIDINE HCL ER 0.1 MG TABLET has been published 160 times since Sep 13, 2023, and over the history we have for it it has declined 32.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2117 per EA |
|---|---|
| All-time high | $0.3846 (Dec 13, 2023) |
| All-time low | $0.2005 (Nov 20, 2024) |
| 52-week high | $0.2846 |
| 52-week low | $0.2117 |
| Median price | $0.2740 |
| Average price | $0.2764 |
| Largest weekly change | -37.3% (Nov 20, 2024) |
| Weeks tracked | 160 |
| Tracking since | Sep 13, 2023 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 89% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
BluePoint Laboratories manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Clonidine hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Central alpha-2 Adrenergic Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CLONIDINE HCL ER 0.1 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CLONIDINE HCL ER 0.1 MG TABLET, manufactured by BluePoint Laboratories, is $0.2117 per EA (NDC 68001056806), effective Sep 30, 2026.
How has the price of CLONIDINE HCL ER 0.1 MG TABLET changed over time?
Over the history we have for it, the NADAC for CLONIDINE HCL ER 0.1 MG TABLET has declined 32.2%. It has been tracked across 160 weekly CMS publications since Sep 13, 2023.
What are the highest and lowest recorded NADAC prices for CLONIDINE HCL ER 0.1 MG TABLET?
Since Sep 13, 2023, the NADAC for CLONIDINE HCL ER 0.1 MG TABLET has ranged from a low of $0.2005 (Nov 20, 2024) to a high of $0.3846 (Dec 13, 2023), with a median of $0.2740 per EA.
Are there cheaper alternatives to CLONIDINE HCL ER 0.1 MG TABLET?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CLONIDINE HCL 0.1 MG TABLET, is $0.0241 per EA — about 89% below CLONIDINE HCL ER 0.1 MG TABLET.
Who manufactures CLONIDINE HCL ER 0.1 MG TABLET?
CLONIDINE HCL ER 0.1 MG TABLET (NDC 68001056806) is labeled by BluePoint Laboratories, and CMS classifies it as a generic product.